Wave Life Sciences Ltd

(NASDAQ:WVE)

Latest On Wave Life Sciences Ltd (WVE):

Date/Time Type Description Signal Details
2023-05-23 19:33 ESTNewsWave Life Sciences crashes on decision to drop neurology asset on trial setbackN/A
2023-05-03 17:10 ESTNewsWave Life Sciences GAAP EPS of -$0.27 misses by $0.23, revenue of $12.93M misses by $25.67MN/A
2023-05-03 17:10 ESTNewsWave Life Sciences Ltd. (WVE) Q1 2023 Earnings Call TranscriptN/A
2023-05-02 16:03 ESTNewsWave Life Sciences Q1 2023 Earnings PreviewN/A
2023-03-22 19:19 ESTNewsWave Life Sciences GAAP EPS of -$0.47 misses by $0.06, revenue of $1.24M misses by $1.16MN/A
2023-03-22 19:18 ESTNewsWave Life Sciences Ltd. 2022 Q4 - Results - Earnings Call PresentationN/A
2023-03-22 19:18 ESTNewsWave Life Sciences Ltd (WVE) Q4 2022 Earnings Call TranscriptN/A
2023-03-21 11:59 ESTNewsWave Life Sciences Q4 2022 Earnings PreviewN/A
2023-03-13 05:38 ESTNewsRAPT Therapeutics, Repare Therapeutics among biotechs to disclose exposure to Silicon Valley BankN/A
2023-01-08 08:22 ESTNewsWave Life Sciences: Huntington's Hypotheses, GSK Collaboration Catalysts To Move The NeedleN/A
2022-12-13 14:27 ESTNewsWave Life stock surges 20% in team up with GSK for genetic diseasesN/A
2022-11-11 01:23 ESTNewsWave Life Sciences Ltd. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-11 01:23 ESTNewsWave Life Sciences Ltd. (WVE) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 07:50 ESTNewsWave Life Sciences GAAP EPS of -$0.42 beats by $0.08, revenue of $0.29M misses by $5.11MN/A
2022-11-09 14:49 ESTNewsWave Life Sciences Q3 2022 Earnings PreviewN/A
2022-09-21 00:13 ESTNewsWave Life's WVE-003 shows promise in interim data of Huntington's disease trialN/A
2022-08-11 17:59 ESTNewsWave Life Sciences GAAP EPS of -$0.62 misses by $0.08, revenue of $0.37MN/A
2022-08-11 17:59 ESTNewsWave Life Sciences Ltd. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-11 17:59 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 01:42 ESTNewsWave Life Sciences Q2 2022 Earnings PreviewN/A
2022-06-22 10:01 ESTNewsRa Capital Management raises passive stake in Wave Life SciencesN/A
2022-06-15 00:46 ESTNewsWave Life Sciences to raise $70M in stock offeringN/A
2022-05-14 05:36 ESTNewsWave Life Sciences Ltd.'s (WVE) CEO Paul Bolno on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-14 05:36 ESTNewsWave Life Sciences slips as H.C. Wainwright lowers targetN/A
2022-05-13 02:49 ESTNewsWave Life Sciences GAAP EPS of -$0.62 misses by $0.06, revenue of $1.75M misses by $2.11MN/A
2022-05-13 02:49 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-13 02:49 ESTNewsWave Life Sciences Ltd. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-12 06:46 ESTNewsWave Life Sciences Q1 2022 Earnings PreviewN/A
2022-04-05 01:08 ESTNewsWave Life gains most in more than a year after early-stage data for ALS drugN/A
2022-03-31 02:14 ESTNewsWave Life Sciences (WVE) Investor Presentation - SlideshowN/A
2022-03-05 07:12 ESTNewsWave Life Sciences Ltd. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-03-03 20:07 ESTNewsWave Life Sciences GAAP EPS of -$0.61 misses by $0.06, revenue of $1.76M misses by $11.98MN/A
2022-03-03 20:06 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-03 02:56 ESTNewsWave Life Sciences Q4 2021 Earnings PreviewN/A
2022-01-25 21:00 ESTNewsWave Life Sciences' FTD, ALS clinical program to get investment from 2 organizationsN/A
2021-11-10 18:38 ESTNewsWave Life Sciences EPS beats by $0.52, beats on revenueN/A
2021-11-10 18:37 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 18:37 ESTNewsWave Life Sciences Ltd. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-09 19:57 ESTNewsWave Life Sciences Q3 2021 Earnings PreviewN/A
2021-10-18 23:49 ESTNewsWave Life Sciences, Takeda amend CNS research collaborationN/A
2021-10-18 23:49 ESTNewsTakeda discontinues research with Wave for certain CNS programs; Wave to get $22.5MN/A
2021-09-30 02:27 ESTNewsDosing underway in Wave Life's mid-stage WVE-N531 study in Duchenne muscular dystrophyN/A
2021-09-29 03:19 ESTNewsWave Life Sciences falls after presentation on its RNA editing capability (Updated)N/A
2021-09-09 14:39 ESTNewsWave Life Sciences gets dosing underway in early-stage Huntington’s disease trialN/A
2021-08-17 03:33 ESTNewsWave Life Sciences Ltd. 2021 Q2 - Results - Earnings Call PresentationN/A
2021-08-08 22:24 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-05 16:13 ESTNewsWave Life Sciences EPS misses by $0.14, misses on revenueN/A
2021-07-22 09:27 ESTNewsWave Life Sciences posts proof-of-concept data from genetic disorder studyN/A
2021-07-22 08:54 ESTNewsDosing underway in Wave Life Sciences' mid-stage WVE-004 study in neurodegenerative diseasesN/A
2021-03-29 20:19 ESTNewsWave Life Sciences falls on setback for Huntington’s disease trial (updated)N/A

About Wave Life Sciences Ltd (WVE):

Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It develops WVE-120101 and WVE-120102, a stereopure therapeutic candidates, which are in Phase 1b/2a clinical trials for the treatment of Huntington's disease (HD); WVE-003, mutant huntingtin SNP3 program for the treatment of HD; WVE-004, C9orf72 program for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia; WVE-N531, our Exon 53 program for the treatment of Duchenne muscular dystrophy; and ATXN3 program in SCA3. The company has collaboration agreements with Pfizer Inc., Takeda Pharmaceutical Company Limited, University of Oxford, and University of Massachusetts. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore.

See Advanced Chart

General

  • Name Wave Life Sciences Ltd
  • Symbol WVE
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 217
  • Fiscal Year EndDecember
  • IPO Date2015-11-11
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.wavelifesciences.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 17.92
  • Price/Book (Most Recent Quarter) 5.85
  • Enterprise Value Revenue 16.38
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.80
  • Next Year EPS Estimate -$2.16
  • Next Quarter EPS Estimate -$0.53
  • Operating Margin -764%
  • Return on Assets -34%
  • Return on Equity -185%
  • Revenue 20.08 million
  • Earnings Per Share -$5.15
  • Revenue Per Share $0.51
  • Gross Profit -110867000
  • Quarterly Earnings Growth 293.3%
View More

Highlights

  • Market Capitalization 486.05 million
  • EBITDA -173971008
  • PE Ratio -9.74
  • Analyst Target Price $16.86
  • Book Value Per Share $1.70
View More

Share Statistics

  • Shares Outstanding 49 million
  • Shares Float 31.16 million
  • % Held by Insiders 1297%
  • % Held by Institutions 76.71%
  • Shares Short 4.92 million
  • Shares Short Prior Month 4.38 million
  • Short Ratio 9.71
  • Short % of Float 13%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 0.37
  • 52 Week High $19.98
  • 52 Week Low $6.76
  • 50 Day Moving Average 10.18
  • 200 Day Moving Average 9.71
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Wave Life Sciences Ltd (WVE) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Wave Life Sciences Ltd (WVE) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-04$9.44 million-$0.59-$0.602.14%
2020-09-302020-11-09$N/A-$0.86-$0.73-17.81%
2020-06-302020-08-10$N/A-$1.15-$1.07-7.48%
2020-03-312020-05-11$4.16 million-$1.38-$1.32-4.41%
2019-12-312020-03-02$2.4 million-$1.65-$1.46-13.35%
2019-09-302019-11-05$2.93 million-$1.48-$1.37-8.37%
2019-06-302019-07-29$7.63 million-$1.22-$1.00-22.31%
2019-03-312019-05-10$3.03 million-$1.36-$1.20-13.1%
2018-12-312019-03-01$3.62 million-$1.28-$1.25-2.81%
2018-09-302018-11-09$4.49 million-$1.28-$1.24-2.89%
2018-06-302018-08-09$4.88 million-$1.23-$1.10-11.56%
2018-03-312018-05-09$1.42 million-$1.26-$0.91-38.97%
2017-12-312018-03-12$1.68 million-$1.10-$1.04-5.43%
2017-09-302017-11-09$1.32 million-$0.94-$0.984.08%
2017-06-302017-08-09$1.1 million-$0.92-$0.81-13.23%
2017-03-312017-05-10$383000-$0.89-$0.76-17.49%
2016-12-312017-03-16$676000-$0.81-$0.67-20.45%
2016-09-302016-11-09$392000-$0.75-$0.53-41.51%
2016-06-302016-08-15$417000-$0.51-$0.37-37.84%
2016-03-312016-05-16$N/A-$0.36-$0.396.9%
2015-12-312016-03-30$N/A-$0.47-$0.32-46.88%
2015-09-302015-11-11$26000-$0.54-$0.29-86.21%

Wave Life Sciences Ltd (WVE) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Wave Life Sciences Ltd (WVE) Chart:

Wave Life Sciences Ltd (WVE) News:

Below you will find a list of latest news for Wave Life Sciences Ltd (WVE) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Wave Life Sciences Ltd (WVE) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-04-172.510.4CALL0 0543.47TRUE00
2025-04-1759.31CALL0 28286.78TRUE00
2025-04-177.52.29CALL0 104102.49TRUE00
2025-04-17100.15CALL19 202171.04FALSE-0.16-0.52
2025-04-1712.50.02CALL50 245383.73FALSE-0.03-0.6
2025-04-17150.3CALL1 1209203.97FALSE0.255
2025-04-1717.50.05CALL0 1047227.73FALSE00
2025-04-17200.27CALL0 217255.74FALSE00
2025-04-1722.50.25CALL0 136601.17FALSE00
2025-04-17250.15CALL0 36300.01FALSE00
2025-04-17300CALL0 2334.25FALSE00
2025-04-172.50.25PUT0 0335.86FALSE00
2025-04-1750.3PUT0 41130.29FALSE00
2025-04-177.50.18PUT0 109968.51FALSE00
2025-04-17101.17PUT0 485100.98TRUE00
2025-04-1712.52.85PUT0 179269.07TRUE00
2025-04-17155.54PUT0 149127.79TRUE00
2025-04-1717.56.32PUT0 45227.13TRUE00
2025-04-17205.7PUT0 6227.43TRUE00
2025-04-1722.58.9PUT0 20250.66TRUE00
2025-04-17250PUT0 0314.3TRUE00
2025-04-17300PUT0 0404.79TRUE00
2025-05-162.50CALL0 0233.49TRUE00
2025-05-1650CALL0 0144.05TRUE00
2025-05-167.52.92CALL0 9990.16TRUE00
2025-05-16100.65CALL2 21689.69FALSE0.650
2025-05-1612.50.35CALL0 1580.4FALSE00
2025-05-16150.75CALL0 10197.57FALSE00
2025-05-1617.50CALL0 0168.37FALSE00
2025-05-16200CALL0 0177.97FALSE00
2025-05-162.50PUT0 0287.06FALSE00
2025-05-1650PUT0 0161.66FALSE00
2025-05-167.50.4PUT0 188.81FALSE00
2025-05-16101.6PUT0 7091.31TRUE00
2025-05-1612.50PUT0 090.04TRUE00
2025-05-16150PUT0 087.23TRUE00
2025-05-1617.50PUT0 0121.45TRUE00
2025-05-16200PUT0 0166.71TRUE00
2025-07-182.50CALL0 0177.22TRUE00
2025-07-1850CALL0 083.93TRUE00
2025-07-187.52.89CALL0 11493.03TRUE00
2025-07-18101.25CALL0 21585.9FALSE00
2025-07-1812.50.79CALL0 2278.28FALSE00
2025-07-18150.57CALL0 42079.05FALSE00
2025-07-1817.50.6CALL0 19695.59FALSE00
2025-07-18200.4CALL0 29116.37FALSE00
2025-07-1822.50.45CALL0 1126.66FALSE00
2025-07-18250.15CALL0 2135.56FALSE00
2025-07-18300.33CALL0 1150.36FALSE00
2025-07-182.50PUT0 0216.61FALSE00
2025-07-1850PUT0 0112.84FALSE00
2025-07-187.50.88PUT2 180.25FALSE0.880
2025-07-18102.37PUT4 6482.11TRUE0.670.39
2025-07-1812.53.6PUT0 1477.73TRUE00
2025-07-18155.38PUT0 4382.72TRUE00
2025-07-1817.58.26PUT0 193.04TRUE00
2025-07-18200PUT0 0111.35TRUE00
2025-07-1822.50PUT0 0122.59TRUE00
2025-07-18250PUT0 0119.57TRUE00
2025-07-18300PUT0 0183.95TRUE00
2025-10-172.50CALL0 0103.72TRUE00
2025-10-1755.7CALL0 277.63TRUE00
2025-10-177.52.8CALL0 2774.03TRUE00
2025-10-17102.11CALL0 17954.62FALSE00
2025-10-1712.51.21CALL0 1580.78FALSE00
2025-10-17150.75CALL1 1583.93FALSE0.750
2025-10-1717.51.35CALL0 168.43FALSE00
2025-10-17200.55CALL0 12383.99FALSE00
2025-10-172.50PUT0 0305.92FALSE00
2025-10-1750PUT0 086.71FALSE00
2025-10-177.51.23PUT52 373.24FALSE1.230
2025-10-17101.94PUT0 5372.04TRUE00
2025-10-1712.53.85PUT0 3572.17TRUE00
2025-10-17150PUT0 071.76TRUE00
2025-10-1717.57.17PUT0 687.37TRUE00
2025-10-17200PUT0 073.3TRUE00

Latest WVE Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST17$1.995
Jun 13, 2022 7:59 PM EST100$2
Jun 13, 2022 7:59 PM EST17$1.995
Jun 13, 2022 7:59 PM EST17$1.995
Jun 13, 2022 7:59 PM EST100$1.995

Wave Life Sciences Ltd (WVE) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2019-08-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1631574/000000000019012261/0000000000-19-012261-index.htm
2019-11-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1631574/000000000019015921/0000000000-19-015921-index.htm
2019-12-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1631574/000000000019016177/0000000000-19-016177-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000008025519002715/0000080255-19-002715-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000008025520001311/0000080255-20-001311-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000021545719006909/0000215457-19-006909-index.htm
2019-03-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000021545719007594/0000215457-19-007594-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000083423720008192/0000834237-20-008192-index.htm
2020-08-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000089542120000470/0000895421-20-000470-index.htm
2018-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318022514/0000899243-18-022514-index.htm
2018-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318022515/0000899243-18-022515-index.htm
2018-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318025318/0000899243-18-025318-index.htm
2018-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318025320/0000899243-18-025320-index.htm
2018-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2018-11-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318029157/0000899243-18-029157-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004460/0000899243-19-004460-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004462/0000899243-19-004462-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004464/0000899243-19-004464-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004466/0000899243-19-004466-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004467/0000899243-19-004467-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007106/0000899243-19-007106-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007110/0000899243-19-007110-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007112/0000899243-19-007112-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007113/0000899243-19-007113-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007114/0000899243-19-007114-index.htm
2019-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-07-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319019395/0000899243-19-019395-index.htm
2019-08-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021292/0000899243-19-021292-index.htm
2019-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021293/0000899243-19-021293-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021959/0000899243-19-021959-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021962/0000899243-19-021962-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021963/0000899243-19-021963-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021965/0000899243-19-021965-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021966/0000899243-19-021966-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021967/0000899243-19-021967-index.htm
2019-09-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023028/0000899243-19-023028-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023032/0000899243-19-023032-index.htm
2019-09-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023033/0000899243-19-023033-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023034/0000899243-19-023034-index.htm
2019-09-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023035/0000899243-19-023035-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023038/0000899243-19-023038-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319027985/0000899243-19-027985-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319028606/0000899243-19-028606-index.htm
2020-01-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320001393/0000899243-20-001393-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320003379/0000899243-20-003379-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320005342/0000899243-20-005342-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320005346/0000899243-20-005346-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320005349/0000899243-20-005349-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320005351/0000899243-20-005351-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007277/0000899243-20-007277-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007281/0000899243-20-007281-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007282/0000899243-20-007282-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007284/0000899243-20-007284-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007285/0000899243-20-007285-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023078/0000899243-20-023078-index.htm
2020-08-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023079/0000899243-20-023079-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023080/0000899243-20-023080-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023085/0000899243-20-023085-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023086/0000899243-20-023086-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023087/0000899243-20-023087-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023088/0000899243-20-023088-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023089/0000899243-20-023089-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023092/0000899243-20-023092-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023093/0000899243-20-023093-index.htm
2020-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023540/0000899243-20-023540-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320025614/0000899243-20-025614-index.htm
2020-01-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000090221920000204/0000902219-20-000204-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000110465920021834/0001104659-20-021834-index.htm
2019-01-28SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1631574/000114420419003157/0001144204-19-003157-index.htm
2019-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000114420419003160/0001144204-19-003160-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000114420419008078/0001144204-19-008078-index.htm
2018-09-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518270464/0001193125-18-270464-index.htm
2018-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518290300/0001193125-18-290300-index.htm
2018-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518291962/0001193125-18-291962-index.htm
2018-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518295345/0001193125-18-295345-index.htm
2018-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518323137/0001193125-18-323137-index.htm
2018-11-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312518323760/0001193125-18-323760-index.htm
2018-12-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518342992/0001193125-18-342992-index.htm
2019-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519001144/0001193125-19-001144-index.htm
2019-01-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1631574/000119312519014851/0001193125-19-014851-index.htm
2019-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519014884/0001193125-19-014884-index.htm
2019-01-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1631574/000119312519015961/0001193125-19-015961-index.htm
2019-01-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519015976/0001193125-19-015976-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519040844/0001193125-19-040844-index.htm
2019-02-20SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1631574/000119312519045277/0001193125-19-045277-index.htm
2019-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519059251/0001193125-19-059251-index.htm
2019-03-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1631574/000119312519074933/0001193125-19-074933-index.htm
2019-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519107259/0001193125-19-107259-index.htm
2019-04-2910-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1631574/000119312519125660/0001193125-19-125660-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519143674/0001193125-19-143674-index.htm
2019-05-10S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1631574/000119312519144278/0001193125-19-144278-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519165571/0001193125-19-165571-index.htm
2019-06-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519182697/0001193125-19-182697-index.htm
2019-07-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519205421/0001193125-19-205421-index.htm
2019-08-06S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1631574/000119312519214152/0001193125-19-214152-index.htm
2019-08-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519214169/0001193125-19-214169-index.htm
2019-08-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1631574/000119312519218981/0001193125-19-218981-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519221246/0001193125-19-221246-index.htm
2019-08-168-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519223468/0001193125-19-223468-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519238229/0001193125-19-238229-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519263797/0001193125-19-263797-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519284729/0001193125-19-284729-index.htm
2019-11-05S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519284817/0001193125-19-284817-index.htm
2019-12-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1631574/000119312519304738/0001193125-19-304738-index.htm
2019-12-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519314469/0001193125-19-314469-index.htm
2019-12-23SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519322733/0001193125-19-322733-index.htm
2019-12-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519325442/0001193125-19-325442-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520005483/0001193125-20-005483-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520005882/0001193125-20-005882-index.htm
2020-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520026760/0001193125-20-026760-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520037841/0001193125-20-037841-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520038291/0001193125-20-038291-index.htm
2020-03-02POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1631574/000119312520057766/0001193125-20-057766-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520057791/0001193125-20-057791-index.htm
2020-03-02POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1631574/000119312520057905/0001193125-20-057905-index.htm
2020-04-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520107212/0001193125-20-107212-index.htm
2020-04-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520117339/0001193125-20-117339-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520138276/0001193125-20-138276-index.htm
2020-06-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520181069/0001193125-20-181069-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520214106/0001193125-20-214106-index.htm
2020-08-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520214144/0001193125-20-214144-index.htm
2020-08-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520214223/0001193125-20-214223-index.htm
2020-08-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520223731/0001193125-20-223731-index.htm
2020-08-198-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520224764/0001193125-20-224764-index.htm
2020-08-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520229903/0001193125-20-229903-index.htm
2020-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520241608/0001193125-20-241608-index.htm
2020-09-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1631574/000119312520251261/0001193125-20-251261-index.htm
2020-09-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520251297/0001193125-20-251297-index.htm
2020-09-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1631574/000119312520252307/0001193125-20-252307-index.htm
2020-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520252347/0001193125-20-252347-index.htm
2020-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520254552/0001193125-20-254552-index.htm
2020-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520260543/0001193125-20-260543-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000127417319000113/0001274173-19-000113-index.htm
2019-08-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000127417319000120/0001274173-19-000120-index.htm
2020-01-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000127417320000004/0001274173-20-000004-index.htm
2020-01-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000149315220000835/0001493152-20-000835-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459018028757/0001564590-18-028757-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1631574/000156459019005671/0001564590-19-005671-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459019018521/0001564590-19-018521-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459019029396/0001564590-19-029396-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459019040431/0001564590-19-040431-index.htm
2020-03-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1631574/000156459020007972/0001564590-20-007972-index.htm
2020-04-2910-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1631574/000156459020019772/0001564590-20-019772-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459020023860/0001564590-20-023860-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459020038620/0001564590-20-038620-index.htm
2019-08-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1631574/999999999519001883/9999999995-19-001883-index.htm
2020-05-01EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1631574/999999999520000974/9999999995-20-000974-index.htm
2018-09-17CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1631574/999999999718007937/9999999997-18-007937-index.htm

Wave Life Sciences Ltd (WVE) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Wave Life Sciences Ltd (WVE). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1297%
Institutional Ownership: 7671%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-02-19Keith RegnanteChief Financial OfficerSell1,298.0036.8447,817.8015,686.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004467/0000899243-19-004467-index.htm
2018-09-24Keith RegnanteChief Financial OfficerSell29,500.0055.001,622,500.0016,984.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025320/0000899243-18-025320-index.htm
2019-02-19Chris FrancisOfficerSell1,709.0036.8462,959.0520,368.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004460/0000899243-19-004460-index.htm
2018-09-24Chris FrancisOfficerSell1,032.0056.0057,792.0022,077.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2018-09-25Chris FrancisOfficerSell10,543.0056.00590,408.0022,077.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2018-09-24Chris FrancisOfficerBuy1,032.002.482,559.3623,109.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2019-02-19Chandra VargeeseSenior VP, Drug DiscoverySell2,055.0036.8475,706.2025,245.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004462/0000899243-19-004462-index.htm
2019-02-19PAUL BOLNOPresident and CEOSell119.0037.474,458.45271,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004464/0000899243-19-004464-index.htm
2019-02-19PAUL BOLNOPresident and CEOSell7,614.0036.38276,997.32271,328.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004464/0000899243-19-004464-index.htm
2020-07-02PAUL BOLNOPresident and CEOSell43,068.0010.26441,877.68272,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-07-02PAUL BOLNOPresident and CEOSell95,921.0010.27985,108.67272,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-08-25PAUL BOLNOPresident and CEOSell25,000.0012.00300,000.00272,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320023540/0000899243-20-023540-index.htm
2020-09-15PAUL BOLNOPresident and CEOSell100,000.0015.001,500,000.00272,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320025614/0000899243-20-025614-index.htm
2018-09-24Chandra VargeeseSenior VP, Drug DiscoverySell3,000.0055.00165,000.0027,300.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025318/0000899243-18-025318-index.htm
2019-03-07Keith RegnanteChief Financial OfficerBuy13,500.0029,186.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007114/0000899243-19-007114-index.htm
2020-08-25PAUL BOLNOPresident and CEOBuy25,000.002.4862,000.00297,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320023540/0000899243-20-023540-index.htm
2019-11-20Gregory L. VerdineDirectorSell2,609.0032.7485,418.6630,000.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319027985/0000899243-19-027985-index.htm
2018-09-24Chandra VargeeseSenior VP, Drug DiscoveryBuy3,000.002.487,440.0030,300.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025318/0000899243-18-025318-index.htm
2020-02-18Chris FrancisOfficerSell2,708.007.8521,257.8031,160.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320005346/0000899243-20-005346-index.htm
2020-07-02PAUL BOLNOPresident and CEOSell4,509.0010.8248,787.38315,249.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-02-18PAUL BOLNOPresident and CEOSell11,451.007.8589,890.35319,758.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320005349/0000899243-20-005349-index.htm
2019-11-20Gregory L. VerdineDirectorSell3,400.0031.59107,406.0032,609.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319027985/0000899243-19-027985-index.htm
2018-09-25Chris FrancisOfficerBuy10,543.002.4826,146.6432,620.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2019-03-07PAUL BOLNOPresident and CEOBuy60,000.00331,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007112/0000899243-19-007112-index.htm
2019-03-15PAUL BOLNOPresident and CEOSell1,763.0046.0081,098.00331,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-03-15PAUL BOLNOPresident and CEOSell8,237.0045.22372,477.14332,972.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-03-07Chris FrancisOfficerBuy13,500.0033,868.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007110/0000899243-19-007110-index.htm
2019-03-15PAUL BOLNOPresident and CEOSell5,065.0045.89232,432.85341,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-03-15PAUL BOLNOPresident and CEOSell34,935.0045.451,587,795.75346,274.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-08-05Mark BaldryChief Commerical OfficerBuy35,000.0035,000.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319021293/0000899243-19-021293-index.htm
2019-11-20Gregory L. VerdineDirectorSell24,030.0030.27727,388.1036,009.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319027985/0000899243-19-027985-index.htm
2020-07-02PAUL BOLNOPresident and CEOSell4,079.0010.9144,501.89368,102.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-02-18Chandra VargeeseSenior VP, Drug DiscoverySell3,188.007.8525,025.8037,057.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320005342/0000899243-20-005342-index.htm
2020-07-02PAUL BOLNOPresident and CEOBuy100,000.002.48248,000.00372,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-09-15PAUL BOLNOPresident and CEOBuy100,000.002.48248,000.00372,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320025614/0000899243-20-025614-index.htm
2019-02-19Michael A. PanzaraFranchise Lead, NeurologySell1,837.0036.8467,673.9837,388.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004466/0000899243-19-004466-index.htm
2019-03-15PAUL BOLNOPresident and CEOBuy50,000.002.48124,000.00381,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-08-05Mark BaldryChief Commerical OfficerBuy4,000.0039,000.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319021293/0000899243-19-021293-index.htm
2020-02-18Michael A. PanzaraChief Medical OfficerSell2,981.007.8523,400.8539,349.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320005351/0000899243-20-005351-index.htm
2019-03-07Chandra VargeeseSenior VP, Drug DiscoveryBuy15,000.0040,245.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007106/0000899243-19-007106-index.htm
2019-12-03Chandra VargeeseSenior VP, Drug DiscoverySell6,000.0035.00210,000.0040,245.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319028606/0000899243-19-028606-index.htm
2019-07-05Michael A. PanzaraChief Medical OfficerSell445.0027.2612,130.7042,330.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319019395/0000899243-19-019395-index.htm
2019-07-05Michael A. PanzaraChief Medical OfficerSell2,613.0026.8870,237.4442,775.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319019395/0000899243-19-019395-index.htm
2019-03-11Michael A. PanzaraFranchise Lead, NeurologySell7,000.0048.00336,000.0045,388.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007113/0000899243-19-007113-index.htm
2019-12-03Chandra VargeeseSenior VP, Drug DiscoveryBuy6,000.002.4814,880.0046,245.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319028606/0000899243-19-028606-index.htm
2018-09-24Keith RegnanteChief Financial OfficerBuy29,500.0020.89616,255.0046,484.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025320/0000899243-18-025320-index.htm
2019-03-07Michael A. PanzaraFranchise Lead, NeurologyBuy15,000.0052,388.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007113/0000899243-19-007113-index.htm
2018-11-14Gregory L. VerdineDirectorSell4,300.0039.52169,936.0060,039.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318029157/0000899243-18-029157-index.htm
2020-02-03David G GaieroInterim CFOSell651.007.004,557.006,392.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320003379/0000899243-20-003379-index.htm
2018-11-14Gregory L. VerdineDirectorSell10,700.0038.59412,913.0064,339.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318029157/0000899243-18-029157-index.htm
2019-01-24RA CAPITAL MANAGEMENT, LLCDirectorBuy263,158.0038.0010,000,004.007,775,207.00https://www.sec.gov/Archives/edgar/data/1631574/000114420419003160/0001144204-19-003160-index.htm